Abstract

A 55-year-old man with nonischemic dilated cardiomyopathy who had undergone HeartMate II (HM2) (Thoratec, Pleasanton, California) implantation for destination therapy was readmitted 1.5 years later because of low-flow alarms with dizziness. Transesophageal echocardiogram showed decreased velocity

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.